Cargando…

Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses

Colorectal carcinoma (CRC) is a malignant tumor of the digestive system. Cancer-associated fibroblasts (CAFs) are important cellular elements in the tumor microenvironment of CRC, which contribute to CRC progression and immune escape. To predict the survival outcome and therapeutic responses of CRC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan, Chen, Zhengbo, Zhao, Gang, Li, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154103/ https://www.ncbi.nlm.nih.gov/pubmed/37144239 http://dx.doi.org/10.1155/2023/3781091

Ejemplares similares

Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma
por: Lai, Xixi, et al.
Publicado: (2023)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response
por: Lv, Yiming, et al.
Publicado: (2023)

A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma
por: Yan, Lijun, et al.
Publicado: (2022)

Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer
por: Zheng, Hang, et al.
Publicado: (2021)

An Angiogenic Gene Signature for Prediction of the Prognosis and Therapeutic Responses of Hepatocellular Carcinoma
por: Ci, Hongfei, et al.
Publicado: (2023)

Chemotherapy and prognosis in advanced thymic carcinoma patients
por: Song, Zhengbo, et al.
Publicado: (2015)

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Wu, Jun, et al.
Publicado: (2021)

A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
por: Wang, Yichen, et al.
Publicado: (2023)

The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
por: Wei, Zhengbo, et al.
Publicado: (2021)

A novel disulfidptosis and glycolysis related risk score signature for prediction of prognosis and ICI therapeutic responsiveness in colorectal cancer
por: Li, Jiazheng, et al.
Publicado: (2023)

A nomogram model for predicting prognosis of obstructive colorectal cancer
por: Lv, Jian, et al.
Publicado: (2021)

A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma
por: Dai, Xiaoyan, et al.
Publicado: (2021)

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma
por: Cao, Lu, et al.
Publicado: (2023)

A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
por: Peng, Yang, et al.
Publicado: (2021)

The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications
por: Deng, Longfei, et al.
Publicado: (2021)

Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
por: Togo, Shinsaku, et al.
Publicado: (2013)

Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer
por: Zheng, Hang, et al.
Publicado: (2021)

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma
por: Shi, Congyu, et al.
Publicado: (2021)

Construction of a prognostic signature associated with liver metastases for prognosis and immune response prediction in colorectal cancer
por: Liu, Chang, et al.
Publicado: (2023)

Identification of a TRP channel-related risk model for predicting prognosis and therapeutic effects of patients with hepatocellular carcinoma
por: Pang, Chong, et al.
Publicado: (2023)

Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma
por: Hu, Renzhi, et al.
Publicado: (2022)

Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma
por: Zhang, Yingna, et al.
Publicado: (2022)

Expression of TMED3 is independently associated with colorectal cancer prognosis
por: Wang, Rong-Fei, et al.
Publicado: (2022)

A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma
por: Xu, Feng, et al.
Publicado: (2020)

Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma
por: Xiao, Wanyi, et al.
Publicado: (2022)

Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
por: Chen, Jiewei, et al.
Publicado: (2017)

Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer
por: Zhang, Zhao-Cong, et al.
Publicado: (2021)

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
por: Zhang, Jinbao, et al.
Publicado: (2022)

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Identification of a Gene Signature of Cancer-Associated Fibroblasts to Predict Prognosis in Ovarian Cancer
por: Zeng, Li, et al.
Publicado: (2022)

Construction of a hypoxia-derived gene model to predict the prognosis and therapeutic response of head and neck squamous cell carcinoma
por: Wang, Haibin, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2022)

ULK1: A Promising Biomarker in Predicting Poor Prognosis and Therapeutic Response in Human Nasopharygeal Carcinoma
por: Yun, Miao, et al.
Publicado: (2015)

Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma
por: Qian, Baifeng, et al.
Publicado: (2022)

Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma
por: Wang, Gang, et al.
Publicado: (2022)

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
por: Wang, Licheng, et al.
Publicado: (2023)

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses
por: Cai, Guangzhen, et al.
Publicado: (2022)

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
por: Yang, Yanbing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3gsuub1u3q3a4019f0dhal3ccs